Welcome to
RBP World!
Drugs target to CDK11B
Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
---|---|---|---|---|---|---|
AT-7519 | Small molecule | chronic lymphocytic leukemia | Cyclin-dependent kinase inhibitor | 2.0 | Completed | ClinicalTrials |
AT-7519 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
RONICICLIB | Small molecule | non-small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 1.0 | Withdrawn | ClinicalTrials |
RONICICLIB | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 2.0 | Withdrawn | ClinicalTrials |
AT-7519 | Small molecule | Mantle cell lymphoma | Cyclin-dependent kinase inhibitor | 2.0 | Completed | ClinicalTrials |
RONICICLIB | Small molecule | small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 1.0 | Terminated | ClinicalTrials |
AZD-5438 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
RONICICLIB | Small molecule | small cell lung carcinoma | Cyclin-dependent kinase inhibitor | 2.0 | Terminated | ClinicalTrials |
AT-7519 | Small molecule | lymphoma | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
RONICICLIB | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |
PHA-793887 | Small molecule | neoplasm | Cyclin-dependent kinase inhibitor | 1.0 | Terminated | ClinicalTrials |
AT-7519 | Small molecule | multiple myeloma | Cyclin-dependent kinase inhibitor | 1.0 | Completed | ClinicalTrials |